Is NeoGenomics, Inc. overvalued?

NeoGenomics, Inc. (NEO) — key valuation metrics and fundamentals.

No verdict

Price

$15.94

Fair value

—

Current P/E

—

Normal P/E

45.0

Market cap

$409.6M

Dividend yield

2.4%

Return on equity

-6.3%

Sector

Healthcare

Fair value compares NEO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks